Panel Discussion: AI and Digital Pathology – Enabling Next-Gen Treatments & Diagnostics
Time: 2:15 pm
day: Day Three Track A
Details:
- What impact does artificial intelligence (AI) and digital pathology (DP) have on biomarker strategy and drug development?
- How novel treatment modalities are driving innovative assays and AI-powered scoring frameworks
- How AI-powered biomarkers can be deployed for trial enrollment and patient selection
